Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits.
about
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)Clinical and molecular delineation of the 17q21.31 microdeletion syndromeGlial Tau Pathology in Tauopathies: Functional ConsequencesFrontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutationsAxonal transport: cargo-specific mechanisms of motility and regulationClinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasInvited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimagingReduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutationsRapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R.No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease.Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.Familial conformational diseases and dementias.Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathiesStudies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases.The cytoskeleton in neurodegenerative diseases.Protein aggregates and dementia: is there a common toxicity?Disordered proteins in dementia.A network of RNA and protein interactions in Fronto Temporal Dementia.A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease : a comparative studyStructural analysis of Pick's disease-derived and in vitro-assembled tau filamentsNeuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesTau alternative splicing and frontotemporal dementia.Case records of the Massachusetts General Hospital. Case 9-2015. A 31-year-old man with personality changes and progressive neurologic decline.Tau as a therapeutic target in neurodegenerative disease.The role of tau in neurodegenerationTau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathiesThe birth and early evolution of the frontotemporal dementia (FTD) concept.Frontotemporal dementia: implications for understanding Alzheimer disease.Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.Presymptomatic semantic impairment in a case of fronto-temporal lobar degeneration associated with the +16 mutation in MAPT.Tau gene mutation K257T causes a tauopathy similar to Pick's disease.Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease.MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms.Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.Pick's disease with neuronal four-repeat tau accumulation in the basal ganglia, brain stem nuclei and cerebellum.
P2860
Q21203040-2F653FE6-8C52-4D0F-BC81-8219D5220861Q24624737-9EA88653-64C6-4A51-ADDC-172447633CA9Q26765365-4BB53F38-9A74-4819-8F13-311FE6B59AE2Q26777247-92D75560-EED6-4996-B6AA-4CBD2B82105EQ26827748-7861F1B1-B5CE-4919-8C81-14516DE9E746Q27003078-41849A1F-CE6C-4B99-8D26-F31FB023CDE6Q27020981-FBAA67DE-D37A-4016-848E-3FAE1A985A50Q28577828-385A6062-A5C1-415D-8990-F941A979A059Q30394767-2AB5E6A2-41FE-4849-9FA4-A41083471C04Q33309746-B982B3DB-87CB-454D-ACDD-02FF03390E8CQ33393896-636C7CF8-816A-4733-9F25-1E00DD1F3FF8Q34138183-37337E1B-1044-474D-AB6B-FC04C9D2E3E0Q34138249-461EB776-1FC0-4DA1-9E6B-F0D582FACA1CQ34154643-D0200229-B176-4406-AB38-446DCAAD9B3FQ34443878-FDF5F402-BFA8-4712-8E6D-17DD8BDCCDB5Q34446779-C239620B-D106-4EBF-A273-A232195B624DQ34498308-853AD4EE-0436-4C36-827B-867F197EA16FQ34952164-94070675-6DE2-4158-B321-8BB8C12D834AQ35194634-3E81A9A9-0ECB-435F-A9C3-8C4C44D2C383Q35213879-EECE6520-8713-43BC-8012-911D92463857Q35523801-62150B06-0DDE-435E-BA6E-C2505A14C6ABQ35789255-E7F83965-0D74-41D2-9134-0FC80D49C4ECQ35841983-5D6BF431-67FF-4988-89A5-3FEB7A0257C9Q35854093-9B3D9669-A0F1-4171-A0F5-1E8F4960675EQ36326650-9FDC7184-B879-481D-BA9A-BADC6BDEE35AQ36696585-21C4613F-747E-4527-96CB-B0CA3178A2A8Q36970350-3EF23AEE-F5A5-4BA3-BDAA-AA6A8C69E254Q37145919-A691A30A-F8C9-42C9-9A32-13C35FB27FC1Q37309546-D1FCFED1-144B-4360-B6B1-78224C6FBF9DQ37885814-D2F5887B-6BF8-486F-B5E7-D1F2CE47195FQ37987142-9856AA7C-3EDA-4777-900D-244E102E5FF5Q38382217-C48789FC-5C66-4E86-AD86-68E918F9D779Q38411508-9F0FA6B4-49E4-4250-A844-4AB2CCA556D4Q38442790-6C3E97B6-616F-40E6-B1B5-F00B945DA23FQ39645458-C3CDAB43-F474-44F9-8C45-5B45302C1D51Q43339552-B2E7C6B9-76D1-4072-A92B-73BDEDB45B4EQ46441393-9B0E51A1-E711-4556-8C95-142C39D3480FQ46985283-529BDCDA-7D12-443C-B4DB-DD3EDD91CB98Q47281403-B0689A59-1F92-4DBC-B495-4EED5B3D4C44Q48154400-5122ABB6-8717-4669-9B1F-F6B48FD84DFD
P2860
Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Tau gene mutation G389R causes ...... nclusions and axonal deposits.
@en
Tau gene mutation G389R causes ...... nclusions and axonal deposits.
@nl
type
label
Tau gene mutation G389R causes ...... nclusions and axonal deposits.
@en
Tau gene mutation G389R causes ...... nclusions and axonal deposits.
@nl
prefLabel
Tau gene mutation G389R causes ...... nclusions and axonal deposits.
@en
Tau gene mutation G389R causes ...... nclusions and axonal deposits.
@nl
P2093
P1476
Tau gene mutation G389R causes ...... inclusions and axonal deposits
@en
P2093
J R Murrell
M G Spillantini
M Guazzelli
M Hasegawa
R A Crowther
P304
P356
10.1097/00005072-199912000-00002
P577
1999-12-01T00:00:00Z